Brief: Can Fite Biopharma Ltd Says Positive Data From Phase IIA Can-Fite Nash Study Published In Leading Peer Reviewed Scientific Journal
21/10/2021 12:43
Oct 21 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* POSITIVE DATA FROM PHASE IIA CAN-FITE NASH STUDY PUBLISHED
IN
LEADING PEER REVIEWED SCIENTIFIC JOURNAL
Source text for Eikon: ID:nBw1b53xfa
Further company coverage: CANF.TA
((reuters.briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage